• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于药效团和虚拟筛选方法的药物设计

Drug Design by Pharmacophore and Virtual Screening Approach.

作者信息

Giordano Deborah, Biancaniello Carmen, Argenio Maria Antonia, Facchiano Angelo

机构信息

National Research Council, Institute of Food Science, Via Roma 64, 83110 Avellino, Italy.

Doctorate School in Computational and Quantitative Biology, University of Naples "Federico II", 80100 Naples, Italy.

出版信息

Pharmaceuticals (Basel). 2022 May 23;15(5):646. doi: 10.3390/ph15050646.

DOI:10.3390/ph15050646
PMID:35631472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9145410/
Abstract

Computer-aided drug discovery techniques reduce the time and the costs needed to develop novel drugs. Their relevance becomes more and more evident with the needs due to health emergencies as well as to the diffusion of personalized medicine. Pharmacophore approaches represent one of the most interesting tools developed, by defining the molecular functional features needed for the binding of a molecule to a given receptor, and then directing the virtual screening of large collections of compounds for the selection of optimal candidates. Computational tools to create the pharmacophore model and to perform virtual screening are available and generated successful studies. This article describes the procedure of pharmacophore modelling followed by virtual screening, the most used software, possible limitations of the approach, and some applications reported in the literature.

摘要

计算机辅助药物发现技术减少了开发新型药物所需的时间和成本。随着健康紧急情况以及个性化医疗普及所带来的需求,它们的相关性变得越来越明显。药效团方法是所开发的最有趣的工具之一,通过定义分子与给定受体结合所需的分子功能特征,然后指导对大量化合物进行虚拟筛选以选择最佳候选物。有用于创建药效团模型和进行虚拟筛选的计算工具,并且已产生了成功的研究。本文描述了药效团建模随后进行虚拟筛选的过程、最常用的软件、该方法可能存在的局限性以及文献中报道的一些应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c689/9145410/4adbc6968a48/pharmaceuticals-15-00646-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c689/9145410/8620d9ed2cb8/pharmaceuticals-15-00646-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c689/9145410/1406f0008741/pharmaceuticals-15-00646-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c689/9145410/850df976b246/pharmaceuticals-15-00646-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c689/9145410/4adbc6968a48/pharmaceuticals-15-00646-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c689/9145410/8620d9ed2cb8/pharmaceuticals-15-00646-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c689/9145410/1406f0008741/pharmaceuticals-15-00646-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c689/9145410/850df976b246/pharmaceuticals-15-00646-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c689/9145410/4adbc6968a48/pharmaceuticals-15-00646-g004.jpg

相似文献

1
Drug Design by Pharmacophore and Virtual Screening Approach.基于药效团和虚拟筛选方法的药物设计
Pharmaceuticals (Basel). 2022 May 23;15(5):646. doi: 10.3390/ph15050646.
2
Novel approach for efficient pharmacophore-based virtual screening: method and applications.基于药效团的高效虚拟筛选新方法:方法与应用
J Chem Inf Model. 2009 Oct;49(10):2333-43. doi: 10.1021/ci900263d.
3
Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors.基于药效团模型的虚拟筛选寻找新型布鲁顿酪氨酸激酶抑制剂
J Mol Model. 2019 Jun 6;25(7):179. doi: 10.1007/s00894-019-4047-y.
4
The Development of Pharmacophore Modeling: Generation and Recent Applications in Drug Discovery.药效团模型的发展:生成及在药物发现中的最新应用。
Curr Pharm Des. 2018;24(29):3424-3439. doi: 10.2174/1381612824666180810162944.
5
Discovery of Novel Glucagon Receptor Antagonists Using Combined Pharmacophore Modeling and Docking.结合药效团模型和对接技术发现新型胰高血糖素受体拮抗剂
Iran J Pharm Res. 2018 Fall;17(4):1263-1287.
6
Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.利用药效团、虚拟筛选和分子对接方法探索HIV蛋白酶抑制剂的结构要求以进行先导物识别。
J Mol Graph Model. 2015 Mar;56:20-30. doi: 10.1016/j.jmgm.2014.11.015. Epub 2014 Dec 5.
7
Novel butyrylcholinesterase inhibitors through pharmacophore modeling, virtual screening and DFT-based approaches along-with design of bioisosterism-based analogues.通过基于药效团模型、虚拟筛选和密度泛函理论(DFT)的方法,以及基于生物等排的类似物设计,寻找新型丁酰胆碱酯酶抑制剂。
Biomed Pharmacother. 2017 Jan;85:646-657. doi: 10.1016/j.biopha.2016.11.076. Epub 2016 Nov 27.
8
Epidermal growth factor receptor (EGFR) structure-based bioactive pharmacophore models for identifying next-generation inhibitors against clinically relevant EGFR mutations.基于表皮生长因子受体(EGFR)结构的生物活性药效团模型,用于鉴定针对临床相关EGFR突变的下一代抑制剂。
Chem Biol Drug Des. 2017 Oct;90(4):629-636. doi: 10.1111/cbdd.12977. Epub 2017 May 3.
9
Pharmacophore-based virtual screening.基于药效团的虚拟筛选
Curr Med Chem. 2008;15(10):1018-24. doi: 10.2174/092986708784049630.
10
Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7.基于药效团的虚拟筛选方法鉴定人 Toll 样受体 7 的有效天然调节化合物。
J Biomol Struct Dyn. 2019 Nov;37(18):4721-4736. doi: 10.1080/07391102.2018.1559098. Epub 2019 Jan 21.

引用本文的文献

1
In Silico ADME Methods Used in the Evaluation of Natural Products.用于天然产物评估的计算机辅助ADME方法
Pharmaceutics. 2025 Jul 31;17(8):1002. doi: 10.3390/pharmaceutics17081002.
2
Unveiling Novel Arginase Inhibitors for Cutaneous Leishmaniasis Using Drug Repurposing and Virtual Screening Approaches.利用药物再利用和虚拟筛选方法揭示用于皮肤利什曼病的新型精氨酸酶抑制剂
J Cell Biochem. 2025 Aug;126(8):e70060. doi: 10.1002/jcb.70060.
3
Druggability assessments of small peptides as protein-protein interaction inhibitors targeting EED-EZH2 binding within the Polycomb Repressive Complex 2 (PRC2), an epigenetic regulator.

本文引用的文献

1
DeepFusion: A deep learning based multi-scale feature fusion method for predicting drug-target interactions.深融合:一种基于深度学习的多尺度特征融合方法,用于预测药物-靶标相互作用。
Methods. 2022 Aug;204:269-277. doi: 10.1016/j.ymeth.2022.02.007. Epub 2022 Feb 24.
2
AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/Alsin.基于人工智能的蛋白质结构数据库有潜力加速罕见病研究:AlphaFoldDB 与 IAHSP/Alsin 案例。
Drug Discov Today. 2022 Jun;27(6):1652-1660. doi: 10.1016/j.drudis.2021.12.018. Epub 2021 Dec 25.
3
A General Picture of Cucurbit[8]uril Host-Guest Binding.
小肽作为靶向多梳抑制复合物2(PRC2,一种表观遗传调控因子)中EED-EZH2结合的蛋白质-蛋白质相互作用抑制剂的成药潜力评估。
Mol Divers. 2025 Aug 15. doi: 10.1007/s11030-025-11321-4.
4
Sequence-based virtual screening using transformers.基于序列的使用变压器的虚拟筛选。
Nat Commun. 2025 Jul 28;16(1):6925. doi: 10.1038/s41467-025-61833-8.
5
5-methylcytosine regulated CCNL2 promotes tumorigenesis and cisplatin resistance of ovarian cancer with therapeutic implications.5-甲基胞嘧啶调控的CCNL2促进卵巢癌的肿瘤发生及顺铂耐药并具有治疗意义。
J Ovarian Res. 2025 Jul 24;18(1):162. doi: 10.1186/s13048-025-01753-9.
6
Advances and challenges in drug design against dental caries: Application of approaches.抗龋齿药物设计的进展与挑战:方法的应用
J Pharm Anal. 2025 Jun;15(6):101161. doi: 10.1016/j.jpha.2024.101161. Epub 2024 Dec 9.
7
NMR-Guided Studies to Establish the Binding Interaction between a Peptoid and Protein.核磁共振引导的研究以确定类肽与蛋白质之间的结合相互作用。
J Am Chem Soc. 2025 Jul 15. doi: 10.1021/jacs.5c04064.
8
Progress and challenges for the application of machine learning for neglected tropical diseases.机器学习在 neglected tropical diseases 中的应用进展与挑战。 (注:“neglected tropical diseases”直译为“被忽视的热带病” )
F1000Res. 2025 May 20;12:287. doi: 10.12688/f1000research.129064.2. eCollection 2023.
9
Elucidation of Artemisinin as a Potent GSK3β Inhibitor for Neurodegenerative Disorders via Machine Learning-Driven QSAR and Virtual Screening of Natural Compounds.通过机器学习驱动的定量构效关系和天然化合物虚拟筛选阐明青蒿素作为神经退行性疾病的有效糖原合成酶激酶3β抑制剂。
Pharmaceuticals (Basel). 2025 May 31;18(6):826. doi: 10.3390/ph18060826.
10
Structure-based molecular screening and dynamic simulation of phytocompounds targeting VEGFR-2: a novel therapeutic approach for papillary thyroid carcinoma.基于结构的针对血管内皮生长因子受体-2的植物化合物分子筛选及动力学模拟:一种甲状腺乳头状癌的新型治疗方法
Front Pharmacol. 2025 Jun 9;16:1583329. doi: 10.3389/fphar.2025.1583329. eCollection 2025.
葫芦脲主体-客体包合的总体图景。
J Chem Inf Model. 2021 Dec 27;61(12):6107-6134. doi: 10.1021/acs.jcim.1c01208. Epub 2021 Nov 24.
4
STL1, a New AKT Inhibitor, Synergizes with Flavonoid Quercetin in Enhancing Cell Death in A Chronic Lymphocytic Leukemia Cell Line.STL1,一种新型 AKT 抑制剂,与类黄酮槲皮素协同作用增强慢性淋巴细胞白血病细胞系中的细胞死亡。
Molecules. 2021 Sep 25;26(19):5810. doi: 10.3390/molecules26195810.
5
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
6
An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.计算机辅助药物设计及其在 COVID-19 中的应用的最新综述。
Biomed Res Int. 2021 Jun 24;2021:8853056. doi: 10.1155/2021/8853056. eCollection 2021.
7
Accurate Receptor-Ligand Binding Free Energies from Fast QM Conformational Chemical Space Sampling.从快速 QM 构象化学空间采样中获得准确的受体-配体结合自由能。
Int J Mol Sci. 2021 Mar 17;22(6):3078. doi: 10.3390/ijms22063078.
8
Structure-based molecular modeling in SAR analysis and lead optimization.基于结构的分子建模在构效关系分析和先导化合物优化中的应用
Comput Struct Biotechnol J. 2021 Mar 4;19:1431-1444. doi: 10.1016/j.csbj.2021.02.018. eCollection 2021.
9
Virtual Screening of Natural Compounds as Potential PIK-AKT1 Signaling Pathway Inhibitors and Experimental Validation.虚拟筛选天然化合物作为潜在的 PIK-AKT1 信号通路抑制剂及实验验证。
Molecules. 2021 Jan 18;26(2):492. doi: 10.3390/molecules26020492.
10
RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences.RCSB 蛋白质数据库:用于基础生物学、生物医学、生物技术、生物工程和能源科学等领域的基础研究、应用研究和教育中探索生物大分子三维结构的强大新工具。
Nucleic Acids Res. 2021 Jan 8;49(D1):D437-D451. doi: 10.1093/nar/gkaa1038.